In June 2024, NMPA approved 134 medical devices, including 14 Class III imported products, 11 Class II
imported products, and 109 Class III domestic products.
Below is a list of approved Class III and Class II imported products in June 2024.
On July 19, 2024, China NMPA published an announcement on imported medical devices. In this
announcement, imported medical devices needed for prevention and treatment of
life-threatening diseases now are allowed to apply for sales in designated hospitals without
obtaining NMPA registration certificates.
In recent years, China’s NMPA has been continuously promoting the innovation and development
of the medical device industry. The NMPA has implemented a streamlined approval process for
innovative medical devices, ensuring product safety, effectiveness, and quality control.
This approach includes dedicated personnel, comprehensive guidance, and priority review, all
while maintaining rigorous standards and procedures.
As of now, the NMPA has approved 277 innovative medical devices for market release.
Welcome to our new web page, “Medical Aesthetics — Welcome to the
Chinese Market.” As the medical aesthetics landscape undergoes
significant transformations, our platform serves as a comprehensive
guide to the latest developments in the Chinese market. Explore in-depth
insights into the regulatory upgrades introduced by Chinese authorities,
shaping a new era of compliant development in 2022. From standardizing
industrial standards to the impact on specific products like Ultrasonic
Aesthetic and RadioFrequency devices, we unravel the intricacies of this
evolving industry. Discover the opportunities presented by the Hainan
Boao Lecheng Medical Tourism Pilot Zone, providing instant market access
and regulatory benefits for medical aesthetic products. Stay informed
with our featured news section, keeping you abreast of the latest trends
and breakthroughs in the field of Medical Aesthetics. Join us on this
journey as we navigate the dynamic landscape of medical aesthetics in
China and strive to be at the forefront of industry knowledge and
innovation.
A session on UK-China Medical Device Access to China is scheduled for January 17, 2024, focusing on
navigating the medical device lifecycle and compliance in China. The agenda includes the introduction and
launch of a report, an overview of medical device regulation in China for UK SMEs, strategies to expedite
premarket approvals, and insights into post-market surveillance and compliance obligations. The session aims
to provide information on key regulations, approval processes, and best practices for UK medical device
companies seeking access to the Chinese market. The event will conclude with a Q&A session.
Session 2 on targeting unmet medical needs in China’s growing market, features an agenda encompassing an
introduction, an exploration of the landscape of unmet medical needs in China, with a focus on areas where
UK MedTechs can excel, discussion of “Green Channels” for market access of UK medical devices to China,
highlighting expedited pathways for entry into the Chinese market, and concluding with a Q&A session.
Please click here to review the record of BradyKnows webinar and short videos.
